Posts

Malnutrition in Children Crisis – Asrar Qureshi’s Blog Post #1297

Image
Malnutrition in Children Crisis – Asrar Qureshi’s Blog Post #1297 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1297 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: halit kucukbakar Credit: Soumya Credit: VHL Preamble This blog post is based on recent report by the international group Action Against Hunger. Link at the end. A Silent Emergency: Why Child Malnutrition Demands Pakistan's Immediate Attention Every nation faces moments that test not only its resources but also its conscience. For Pakistan, one such moment is unfolding quietly in Quetta, where an alarming rise in child malnutrition has exposed a humanitarian crisis that deserves far greater public attention. Unlike earthquakes or floods, malnutrition rarely makes dramatic headlines. It develops gradually, often hidden behind closed doors, affecting...
Post a Comment
Read more

AI and the Risk of Losing Human Skills – Suggestion to Tackle – Asrar Qureshi’s Blog Post #1296

Image
AI and the Risk of Losing Human Skills – Suggestion to Tackle – Asrar Qureshi’s Blog Post #1296 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1296 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Tara Winstead Preamble This 2-part blogpost is based on a recent article by Boston Consulting Group. Link to the article at the end. AI Is a Tool, not a Substitute for Thinking: How Organizations Can Preserve Human Intelligence Part 2 of a Two-Part Series Drawing on Boston Consulting Group's research, we saw that AI's greatest danger is not job loss but the gradual erosion of human judgment, critical thinking, creativity, and problem-solving when employees increasingly allow AI to think on their behalf. BCG describes this as distributed de-skilling—a collective decline in organizational capability that occurs when...
Post a Comment
Read more

AI and the Risk of Losing Human Skills – Asrar Qureshi’s Blog Post #1295

Image
AI and the Risk of Losing Human Skills – Asrar Qureshi’s Blog Post #1295 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1295 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Thirdman Preamble This 2-part blogpost is based on a recent article by Boston Consulting Group. Link to the article at the end. When AI Thinks for Us: The Hidden Risk of Losing Our Most Valuable Human Skills Part 1 of a Two-Part Series Artificial Intelligence has become one of the greatest productivity breakthroughs of our generation. From drafting reports and writing computer code to analyzing financial data, designing presentations, summarizing meetings, and answering customer enquiries, Generative AI is transforming how work gets done. Organizations around the world are embracing AI at unprecedented speed because the benefits are undenia...
Post a Comment
Read more

7 Deadly Mistakes New Small Businesses Must Avoid – Asrar Qureshi’s Blog Post #1294

Image
7 Deadly Mistakes New Small Businesses Must Avoid – Asrar Qureshi’s Blog Post #1294 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1294 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Gustavo Fring Preamble This blogpost is based on an article by Daniel Lancaster, CFA. Link to the article at the end. Seven Mistakes That Sink Small Businesses and How Smart Entrepreneurs Avoid Them Starting a business is one of life's most exciting adventures. It is also one of the most demanding. Every successful company, whether it is Apple, Amazon, Toyota, or a neighborhood bakery, began as someone's dream. Behind every thriving enterprise is an entrepreneur who took a risk, believed in an idea, and decided to create something of value. Yet the statistics are sobering. A significant number of new businesses fail within th...
Post a Comment
Read more

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293

Image
The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 3 – Asrar Qureshi’s Blog Post #1293 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1293 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Christopher Moon Credit: Pavel Danilyuk Credit: Yuri Shkoda Preamble In the first two parts of this series, we explored the gradual withdrawal of several multinational pharmaceutical companies (MNCs) from Pakistan and examined its consequences for the healthcare ecosystem. Part 3 of a Three-Part Series The Great Exit: Can Pakistan Bring Global Pharmaceutical Companies Back? The departure of research-based multinational companies has raised an important question.  Can Pakistan once again become an attractive destination for global pharmaceutical investment? The answer is yes, but only if the country ad...
Post a Comment
Read more

The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 2 – Asrar Qureshi’s Blog Post #1292

Image
The Exit of Multinational Pharmaceutical Companies from Pakistan – Part 2 – Asrar Qureshi’s Blog Post #1292 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1292 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: www.kaboompics.com Preamble This is Part 2 of a 3-part series about exit of multinational pharmaceutical companies from Pakistan market. It sets the historical context, documents the major multinational exits, and analyzes the structural reasons behind this trend. Part 2 of a Three-Part Series The Great Exit: What Happens When Multinational Pharmaceutical Companies Leave? In Part 1 of this series, we examined why several multinational pharmaceutical companies (MNCs) have either exited Pakistan or significantly reduced their direct operations. We explored the commercial realities behind their decisions, lik...
Post a Comment
Read more

Why Multinational Pharmaceutical Companies Are Leaving Pakistan – Asrar Qureshi’s Blog Post #1291

Image
Why Multinational Pharmaceutical Companies Are Leaving Pakistan – Asrar Qureshi’s Blog Post #1291 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1291 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Preamble This is Part 1 of a 3-part series about exit of multinational pharmaceutical companies from Pakistan market. It sets the historical context, documents the major multinational exits, and analyzes the structural reasons behind this trend. Part 1 of a Three-Part Series For more than five decades, multinational pharmaceutical companies (MNCs) were synonymous with innovation, quality, ethical promotion, and scientific advancement in Pakistan. They introduced many of the country's first modern medicines, established world-class manufacturing facilities, trained generations of technical staff and medical representatives, ...
Post a Comment
Read more